This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf," cell therapies for serious medical conditions, today published a letter to ...

Objectives This study aimed to identify the predictors of burnout, anxiety and depression among healthcare professionals during the COVID-19 pandemic. Design A secondary quantitative analysis of data ...